IDEX (NYSE:IEX) Releases FY 2026 Earnings Guidance

IDEX (NYSE:IEX) updated its FY 2026 earnings guidance on Wednesday. The company provided EPS guidance of 8.350-8.550 for the period, compared to the consensus EPS estimate of 8.260. The company issued revenue guidance of -. IDEX also updated its Q2 2026 guidance to 2.070-2.120 EPS.

IDEX Price Performance

NYSE:IEX traded up $0.54 during mid-day trading on Thursday, reaching $217.88. 573,270 shares of the stock were exchanged, compared to its average volume of 822,293. The business has a fifty day moving average price of $198.78 and a 200 day moving average price of $187.55. The firm has a market capitalization of $16.20 billion, a PE ratio of 33.99, a PEG ratio of 2.10 and a beta of 0.99. IDEX has a 1-year low of $157.25 and a 1-year high of $223.85. The company has a current ratio of 2.86, a quick ratio of 2.02 and a debt-to-equity ratio of 0.45.

IDEX (NYSE:IEX) last issued its quarterly earnings results on Wednesday, April 29th. The industrial products company reported $2.00 earnings per share for the quarter, beating analysts’ consensus estimates of $1.78 by $0.22. The company had revenue of $886.90 million during the quarter, compared to the consensus estimate of $845.75 million. IDEX had a net margin of 13.98% and a return on equity of 15.03%. IDEX’s revenue was up 8.9% on a year-over-year basis. During the same period in the prior year, the company earned $1.75 EPS. IDEX has set its Q2 2026 guidance at 2.070-2.120 EPS and its FY 2026 guidance at 8.350-8.550 EPS. Research analysts expect that IDEX will post 8.23 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Robert W. Baird set a $257.00 price target on shares of IDEX in a research report on Thursday. Weiss Ratings restated a “hold (c)” rating on shares of IDEX in a report on Monday, April 20th. Oppenheimer reaffirmed an “outperform” rating and set a $242.00 target price on shares of IDEX in a research report on Thursday. Stifel Nicolaus set a $250.00 target price on IDEX in a report on Thursday. Finally, BMO Capital Markets initiated coverage on IDEX in a research note on Friday, March 27th. They issued a “market perform” rating and a $214.00 price target on the stock. Six analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, IDEX has an average rating of “Moderate Buy” and a consensus price target of $232.80.

More IDEX News

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: Q1 results beat and management raised guidance — IDEX reported $2.00 adjusted EPS and $886.9M revenue (both above consensus) and raised FY?2026 adjusted EPS guidance to $8.35–8.55, which underpins the rally as it signals stronger margin and organic growth vs. expectations. IDEX raises annual profit forecast on strong AI data center demand
• Positive Sentiment: Raised near?term visibility — IDEX provided Q2 EPS guidance of $2.07–2.12, helping investors frame near?term momentum and reducing short?term uncertainty. Market commentary and post?earnings analysis say the combination of beat + clearer Q2 outlook drove buying. IDEX jumps on Q1 beat and higher 2026 outlook
• Positive Sentiment: Management tone and call details reinforced demand trends — the earnings call highlighted advantaged market positions and momentum across industrial and engineered?products end markets, which boosted investor confidence. IDEX Q1 2026 Earnings Call Transcript
• Neutral Sentiment: Analyst coverage and notes — fresh analyst commentary (Argus/others) is being issued after the results; some reiterate upside, others simply update models. These reports provide context but not a unanimous directional change. Analyst Report: IDEX Corp
• Neutral Sentiment: Industry write?ups and forecasts — several media pieces summarize the beat and outlook and discuss whether the momentum is sustainable; useful for framing but not new facts. IDEX Stock Forecast: What’s Driving Recent Momentum
• Neutral Sentiment: Separate ticker note — multiple items about IDEX Biometrics (IDXAF) appeared in feeds; that company is unrelated to IEX and should not be conflated. IDEX Biometrics Publishes 2025 Annual and Remuneration Reports
• Negative Sentiment: Mixed positioning and institutional flows — some large institutional rebalancing and a handful of lower analyst targets or profit?taking (documented in post?earnings flow reports) could cap gains and explain intraday pullbacks after the initial surge. IDEX ($IEX) Releases Q1 2026 Earnings

Institutional Trading of IDEX

Several hedge funds and other institutional investors have recently modified their holdings of IEX. CYBER HORNET ETFs LLC acquired a new position in IDEX during the second quarter valued at $35,000. MUFG Securities EMEA plc purchased a new position in IDEX during the 2nd quarter valued at about $39,000. McMillan Office Inc. acquired a new position in shares of IDEX in the 4th quarter valued at about $46,000. Los Angeles Capital Management LLC acquired a new position in shares of IDEX in the 4th quarter valued at about $57,000. Finally, Employees Retirement System of Texas purchased a new stake in shares of IDEX in the third quarter worth approximately $99,000. Institutional investors and hedge funds own 97.96% of the company’s stock.

IDEX Company Profile

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.